分析日: 2025-09-27
| ティッカー | 会社名 | 業種 | 取引所 | スコア | RS順位 | 株価 | 3M成績 | 6M成績 | 12M成績 |
|---|---|---|---|---|---|---|---|---|---|
| ADCT | ADC Therapeutics SA | バイオテクノロジー | NYSE | 10/10 | 92% | $3.65 | +29.1% | +125.9% | +3.2% |
| ADPT | Adaptive Biotechnologies Corporation | バイオテクノロジー | NASDAQ | 10/10 | 92% | $13.22 | +6.4% | +53.3% | +214.4% |
| ALNY | Alnylam Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $446.40 | +29.8% | +47.2% | +47.6% |
| ANIP | ANI Pharmaceuticals, Inc. | 特殊・ジェネリック医薬品 | NASDAQ | 10/10 | 92% | $93.05 | +35.5% | +18.5% | +46.3% |
| AORT | Artivion, Inc. | 医療機器 | NYSE | 10/10 | 92% | $41.06 | +24.9% | +50.2% | +46.1% |
| ATEC | Alphatec Holdings, Inc. | 医療機器 | NASDAQ | 10/10 | 92% | $15.02 | +28.2% | +28.3% | +154.5% |
| AUPH | Aurinia Pharmaceuticals Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $13.14 | +48.0% | +39.4% | +66.4% |
| BBIO | BridgeBio Pharma, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $50.05 | +8.8% | +23.4% | +88.1% |
| BTSG | BrightSpring Health Services, Inc. | Health Information Services | NASDAQ | 10/10 | 92% | $27.39 | +9.0% | +32.8% | +67.0% |
| CDTX | Cidara Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $90.50 | +78.7% | +285.1% | +720.3% |
| CELC | Celcuity Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $50.60 | +271.9% | +375.0% | +236.5% |
| CMPX | Compass Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $3.74 | +36.7% | +68.8% | +100.1% |
| COGT | Cogent Biosciences, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $14.16 | +90.1% | +99.4% | +14.0% |
| ELAN | Elanco Animal Health Incorporated | 特殊・ジェネリック医薬品 | NYSE | 10/10 | 92% | $19.61 | +30.2% | +69.3% | +27.5% |
| FULC | Fulcrum Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $8.84 | +21.4% | +174.6% | +138.7% |
| GH | Guardant Health, Inc. | 診断・研究 | NASDAQ | 10/10 | 92% | $60.03 | +8.2% | +20.0% | +153.1% |
| GRAL | GRAIL, Inc. | 診断・研究 | NASDAQ | 10/10 | 92% | $49.86 | -10.2% | +66.0% | +265.7% |
| HALO | Halozyme Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $73.75 | +34.7% | -3.6% | +15.9% |
| HIMS | Hims & Hers Health, Inc. | 特殊・ジェネリック医薬品 | NYSE | 10/10 | 92% | $58.40 | +10.0% | +81.3% | +222.3% |
| INBX | Inhibrx Biosciences, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $32.68 | +121.9% | +112.3% | +95.8% |
| INDV | Indivior PLC | 特殊・ジェネリック医薬品 | NASDAQ | 10/10 | 92% | $23.92 | +55.2% | +131.1% | +136.8% |
| INSM | Insmed Incorporated | バイオテクノロジー | NASDAQ | 10/10 | 92% | $137.03 | +29.0% | +56.6% | +72.3% |
| IONS | Ionis Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $64.09 | +55.1% | +86.6% | +40.3% |
| IRTC | iRhythm Technologies, Inc. | 医療機器 | NASDAQ | 10/10 | 92% | $170.81 | +3.8% | +43.6% | +118.9% |
| LGND | Ligand Pharmaceuticals Incorporated | バイオテクノロジー | NASDAQ | 10/10 | 92% | $166.51 | +34.2% | +36.3% | +nan% |
| MASS | 908 Devices Inc. | 医療機器 | NASDAQ | 10/10 | 92% | $8.01 | +5.2% | +79.2% | +116.1% |
| MDGL | Madrigal Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $424.23 | +33.1% | +10.3% | +80.1% |
| MEDP | Medpace Holdings, Inc. | 診断・研究 | NASDAQ | 10/10 | 92% | $496.79 | +51.2% | +39.9% | +38.9% |
| MGTX | MeiraGTx Holdings plc | バイオテクノロジー | NASDAQ | 10/10 | 92% | $8.18 | +18.3% | -7.5% | +87.4% |
| MIRM | Mirum Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $72.76 | +35.9% | +39.1% | +70.5% |
| MLYS | Mineralys Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $39.99 | +188.4% | +153.7% | +220.8% |
| MNMD | Mind Medicine (MindMed) Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $10.67 | +57.3% | +53.3% | +62.9% |
| OCUL | Ocular Therapeutix, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $12.53 | +27.9% | +46.2% | +25.6% |
| OPRX | OptimizeRx Corporation | Health Information Services | NASDAQ | 10/10 | 92% | $18.78 | +32.0% | +98.3% | +140.8% |
| PAHC | Phibro Animal Health Corporation | 特殊・ジェネリック医薬品 | NASDAQ | 10/10 | 92% | $38.81 | +44.8% | +61.7% | +59.7% |
| PTGX | Protagonist Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $67.42 | +14.9% | +18.8% | +30.0% |
| RYTM | Rhythm Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $99.16 | +49.8% | +61.8% | +73.7% |
| SCPH | scPharmaceuticals Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $5.65 | +41.2% | +84.1% | +5.7% |
| SIGA | SIGA Technologies, Inc. | 特殊・ジェネリック医薬品 | NASDAQ | 10/10 | 92% | $9.16 | +33.4% | +45.9% | +19.6% |
| STOK | Stoke Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $24.14 | +105.6% | +215.7% | +73.1% |
| TBPH | Theravance Biopharma, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $14.07 | +20.4% | +33.3% | +60.7% |
| TEM | Tempus AI, Inc. | Health Information Services | NASDAQ | 10/10 | 92% | $78.48 | +16.4% | +45.0% | +43.6% |
| TNGX | Tango Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $8.53 | +59.5% | +461.2% | -1.3% |
| WGS | GeneDx Holdings Corp. | 診断・研究 | NASDAQ | 10/10 | 92% | $117.21 | +19.9% | +8.0% | +202.1% |
| XERS | Xeris Biopharma Holdings, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 92% | $8.18 | +68.0% | +27.5% | +176.0% |
| AQST | Aquestive Therapeutics, Inc. | 特殊・ジェネリック医薬品 | NASDAQ | 9/10 | 92% | $5.99 | +73.9% | +79.2% | +7.2% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 9/10 | 92% | $32.80 | +100.5% | +118.2% | +52.8% |
| AVDL | Avadel Pharmaceuticals plc | 特殊・ジェネリック医薬品 | NASDAQ | 9/10 | 92% | $15.34 | +66.2% | +72.4% | +4.8% |
| CORT | Corcept Therapeutics Incorporated | バイオテクノロジー | NASDAQ | 9/10 | 92% | $83.87 | +7.1% | +34.4% | +81.1% |
| CRSP | CRISPR Therapeutics AG | バイオテクノロジー | NASDAQ | 9/10 | 92% | $61.67 | +19.7% | +47.6% | +18.2% |
| EDIT | Editas Medicine, Inc. | バイオテクノロジー | NASDAQ | 9/10 | 92% | $3.24 | +40.2% | +140.1% | -20.5% |
| ETNB | 89bio, Inc. | バイオテクノロジー | NASDAQ | 9/10 | 92% | $14.70 | +42.6% | +62.8% | +82.0% |
| EYPT | EyePoint Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 9/10 | 92% | $13.90 | +40.6% | +119.3% | +54.5% |
| KOD | Kodiak Sciences Inc. | バイオテクノロジー | NASDAQ | 9/10 | 92% | $15.80 | +316.5% | +423.9% | +491.6% |
| PGEN | Precigen, Inc. | バイオテクノロジー | NASDAQ | 9/10 | 92% | $3.51 | +140.1% | +101.6% | +265.4% |
| SUPN | Supernus Pharmaceuticals, Inc. | 特殊・ジェネリック医薬品 | NASDAQ | 9/10 | 92% | $47.03 | +42.1% | +26.5% | +41.0% |
| TRML | Tourmaline Bio, Inc. | バイオテクノロジー | NASDAQ | 9/10 | 92% | $47.74 | +191.4% | +167.6% | +74.9% |
| TSHA | Taysha Gene Therapies, Inc. | バイオテクノロジー | NASDAQ | 9/10 | 92% | $3.25 | +33.6% | +49.3% | +45.6% |
| URGN | UroGen Pharma Ltd. | バイオテクノロジー | NASDAQ | 9/10 | 92% | $18.34 | +26.8% | +44.6% | +26.5% |
| WRBY | Warby Parker Inc. | 医療器具・用品 | NYSE | 9/10 | 92% | $27.60 | +18.7% | +28.7% | +63.7% |
| ZIMV | ZimVie Inc. | 医療機器 | NASDAQ | 9/10 | 92% | $18.91 | +95.1% | +54.2% | +6.5% |
| ARCT | Arcturus Therapeutics Holdings Inc. | バイオテクノロジー | NASDAQ | 8/10 | 92% | $22.17 | +63.3% | +72.3% | -12.1% |
| CHRS | Coherus Oncology, Inc. | バイオテクノロジー | NASDAQ | 8/10 | 92% | $1.50 | +98.4% | +59.5% | +35.4% |
| DNTH | Dianthus Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 8/10 | 92% | $36.71 | +89.9% | +64.5% | +21.4% |
| DSGN | Design Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 8/10 | 92% | $6.57 | +87.8% | +37.0% | +6.0% |
| KYMR | Kymera Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 8/10 | 92% | $56.25 | +21.8% | +70.8% | -7.8% |
| LQDA | Liquidia Corporation | バイオテクノロジー | NASDAQ | 8/10 | 92% | $21.80 | +67.8% | +25.4% | +95.3% |
| NUVB | Nuvation Bio Inc. | バイオテクノロジー | NYSE | 8/10 | 92% | $3.20 | +57.0% | +56.7% | +17.8% |
| PRME | Prime Medicine, Inc. | バイオテクノロジー | NASDAQ | 8/10 | 92% | $5.12 | +100.2% | +138.2% | +34.0% |
| RIGL | Rigel Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 8/10 | 92% | $28.63 | +45.7% | +41.0% | +62.3% |
| TERN | Terns Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 8/10 | 92% | $7.64 | +97.7% | +142.5% | -33.5% |
| TVTX | Travere Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 8/10 | 92% | $25.30 | +63.8% | +9.5% | +57.9% |
| UTHR | United Therapeutics Corporation | 特殊・ジェネリック医薬品 | NASDAQ | 8/10 | 92% | $432.66 | +43.5% | +21.8% | +4.2% |
| DOCS | Doximity, Inc. | Health Information Services | NYSE | 10/10 | 85% | $74.40 | +14.2% | +8.1% | +61.6% |
| PINC | Premier, Inc. | Health Information Services | NASDAQ | 10/10 | 85% | $27.81 | +19.7% | +26.2% | +29.3% |
| ARQT | Arcutis Biotherapeutics, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 84% | $17.57 | +18.2% | -7.4% | +77.0% |
| HCSG | Healthcare Services Group, Inc. | Medical Care Facilities | NASDAQ | 10/10 | 84% | $16.36 | +1.7% | +39.0% | +31.7% |
| IDXX | IDEXX Laboratories, Inc. | 診断・研究 | NASDAQ | 10/10 | 84% | $632.22 | +10.8% | +32.9% | +10.9% |
| ROIV | Roivant Sciences Ltd. | バイオテクノロジー | NASDAQ | 10/10 | 84% | $15.17 | +27.5% | +27.0% | +12.8% |
| ALHC | Alignment Healthcare, Inc. | Healthcare Plans | NASDAQ | 9/10 | 84% | $17.53 | +18.1% | -23.3% | +39.6% |
| RNA | Avidity Biosciences, Inc. | バイオテクノロジー | NASDAQ | 9/10 | 84% | $42.95 | +44.1% | +16.8% | -22.6% |
| BKD | Brookdale Senior Living Inc. | Medical Care Facilities | NYSE | 10/10 | 83% | $8.34 | +12.7% | +16.5% | +9.1% |
| THC | Tenet Healthcare Corporation | Medical Care Facilities | NYSE | 10/10 | 83% | $202.00 | +7.7% | +32.6% | +4.4% |
| ABUS | Arbutus Biopharma Corporation | バイオテクノロジー | NASDAQ | 9/10 | 83% | $4.41 | +35.6% | +6.9% | -3.3% |
| TARS | Tarsus Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 9/10 | 83% | $56.29 | +31.8% | -10.3% | +57.7% |
| ZYME | Zymeworks Inc. | バイオテクノロジー | NASDAQ | 8/10 | 82% | $16.60 | +25.2% | +15.1% | +16.6% |
| IRMD | IRADIMED CORPORATION | 医療機器 | NASDAQ | 10/10 | 81% | $70.27 | +10.4% | +15.0% | +26.2% |
| PTCT | PTC Therapeutics, Inc. | バイオテクノロジー | NASDAQ | 10/10 | 81% | $58.99 | +13.7% | -10.3% | +44.9% |
| ORIC | ORIC Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 8/10 | 81% | $11.12 | +2.4% | +62.0% | -4.9% |
| PHAT | Phathom Pharmaceuticals, Inc. | バイオテクノロジー | NASDAQ | 8/10 | 81% | $11.78 | +15.7% | +59.4% | -49.4% |
| AXGN | Axogen, Inc. | 医療機器 | NASDAQ | 8/10 | 80% | $17.16 | +51.0% | -25.6% | +4.7% |